Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Meyer

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Joint Bone Spine|July 29, 2015
Myositis ossificans circumscriptaPauline Baudart, Johann Cesini, Emmanuel Meyer, et al.
Bioorganic & Medicinal Chemistry Letters|August 13, 2014
Optimization of 2-phenyl-pyrimidine-4-carboxamides towards potent, orally bioavailable and selective P2Y(12) antagonists for inhibition of platelet aggregationEva Caroff, Emmanuel Meyer, Alexander Treiber, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 22, 2024
Oncological outcomes of patients with muscle-invasive bladder cancer treated with trimodal strategy: A French multicentric studyCarolinne Brassart, Alexandre Coutte, Jennifer Wallet, et al.
Cancers|January 21, 2023
Real-Life Study of the Benefit of Concomitant Radiotherapy with Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma (cSCC): A Retrospective Cohort StudyBarbara Bailly-Caillé, Diane Kottler, Rémy Morello, et al.
Frontiers in Oncology|March 20, 2024
Stereotactic body radiotherapy as a viable treatment on extracranial oligometastases in melanoma patients: a retrospective multicentric studyVictorine Trentesaux, Sophie Maiezza, Emilie Bogart, et al.
Journal of Medicinal Chemistry|November 10, 2015
4-((R)-2-{[6-((S)-3-Methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carbonyl]amino}-3-phosphonopropionyl)piperazine-1-carboxylic Acid Butyl Ester (ACT-246475) and Its Prodrug (ACT-281959), a Novel P2Y12 Receptor Antagonist with a Wider Therapeutic Window in the Rat Than ClopidogrelEva Caroff, Francis Hubler, Emmanuel Meyer, et al.
International Journal of Colorectal Disease|December 20, 2019
Implantation of tissue expander prior to irradiation in the era of intensity modulated radiotherapy: impact on the management of patients with pelvic digestive cancersLuc Ollivier, Jean Marc Guilloit, Mélanie Dos Santos, et al.
Frontiers in Oncology|June 18, 2024
Simultaneous integrated boost on pathologic lymph nodes safely improves clinical outcomes compared to sequential boost in locally advanced cervical cancer: a multicenter retrospective studyMarin Guigo, Mohammed Sali Dauda, Justine Lequesne, et al.
European Urology Oncology|May 11, 2024
Combination of Abiraterone Acetate, Prostate Bed Radiotherapy, and Luteinizing Hormone-releasing Hormone Agonists in Biochemically Relapsing Patients After Prostatectomy (CARLHA): A Phase 2 Clinical TrialLoic Ah-Thiane, Loic Campion, Nedjla Allouache, et al.
Communications Medicine|December 23, 2025
Impact of androgen receptor pathway inhibitors on cognitive function in older adults treated for metastatic prostate cancerAntoine Boué, Giulia Baciarello, Emmanuel Meyer, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Joint Bone Spine|July 29, 2015
Myositis ossificans circumscriptaPauline Baudart, Johann Cesini, Emmanuel Meyer, et al.
Bioorganic & Medicinal Chemistry Letters|August 13, 2014
Optimization of 2-phenyl-pyrimidine-4-carboxamides towards potent, orally bioavailable and selective P2Y(12) antagonists for inhibition of platelet aggregationEva Caroff, Emmanuel Meyer, Alexander Treiber, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 22, 2024
Oncological outcomes of patients with muscle-invasive bladder cancer treated with trimodal strategy: A French multicentric studyCarolinne Brassart, Alexandre Coutte, Jennifer Wallet, et al.
Cancers|January 21, 2023
Real-Life Study of the Benefit of Concomitant Radiotherapy with Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma (cSCC): A Retrospective Cohort StudyBarbara Bailly-Caillé, Diane Kottler, Rémy Morello, et al.
Frontiers in Oncology|March 20, 2024
Stereotactic body radiotherapy as a viable treatment on extracranial oligometastases in melanoma patients: a retrospective multicentric studyVictorine Trentesaux, Sophie Maiezza, Emilie Bogart, et al.
Journal of Medicinal Chemistry|November 10, 2015
4-((R)-2-{[6-((S)-3-Methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carbonyl]amino}-3-phosphonopropionyl)piperazine-1-carboxylic Acid Butyl Ester (ACT-246475) and Its Prodrug (ACT-281959), a Novel P2Y12 Receptor Antagonist with a Wider Therapeutic Window in the Rat Than ClopidogrelEva Caroff, Francis Hubler, Emmanuel Meyer, et al.
International Journal of Colorectal Disease|December 20, 2019
Implantation of tissue expander prior to irradiation in the era of intensity modulated radiotherapy: impact on the management of patients with pelvic digestive cancersLuc Ollivier, Jean Marc Guilloit, Mélanie Dos Santos, et al.
Frontiers in Oncology|June 18, 2024
Simultaneous integrated boost on pathologic lymph nodes safely improves clinical outcomes compared to sequential boost in locally advanced cervical cancer: a multicenter retrospective studyMarin Guigo, Mohammed Sali Dauda, Justine Lequesne, et al.
European Urology Oncology|May 11, 2024
Combination of Abiraterone Acetate, Prostate Bed Radiotherapy, and Luteinizing Hormone-releasing Hormone Agonists in Biochemically Relapsing Patients After Prostatectomy (CARLHA): A Phase 2 Clinical TrialLoic Ah-Thiane, Loic Campion, Nedjla Allouache, et al.
Communications Medicine|December 23, 2025
Impact of androgen receptor pathway inhibitors on cognitive function in older adults treated for metastatic prostate cancerAntoine Boué, Giulia Baciarello, Emmanuel Meyer, et al.
Pageof 2